Literature DB >> 7043492

Regulation of prostacyclin and thromboxane production by human umbilical vessels: the effect of estradiol and progesterone in a superfusion model.

U M Mäkilä, L Wahlberg, L Vlinikka, O Ylikorkala.   

Abstract

To study the production of the vasodilatory prostacyclin (PGI2) and vasoconstrictory thromboxane A2 (TxA2) by the human umbilical vessels, vascular segments collected from the cords of healthy newborns (n = 15) after normal pregnancies were superfused with Eagle's medium at 37 degrees C under continuous oxygenation. The stable metabolites of PGI2 and TxA2, 6-keto-prostaglandin F1 alpha and thromboxane B2 (TxB2) respectively, were measured from the superfusates with radioimmunoassays. All vascular segments studied produced 6-keto-PGF1 alpha and TxB2 without any significant difference between the arteries and veins. 6-keto-PGF1 alpha was produced some 10-15 times more than TxB2. 17-beta-estradiol at concentrations of 10, 100 and 1000 ng/ml dose-dependently stimulated the 6-keto-PGF1 alpha formation, but had no effect on TxB2 generation. Progesterone 50, 500 and 5000 ng/ml caused no changes in 6-keto-PGF1 alpha or TxB2 generations but even the smallest concentration of progesterone abolished the stimulating effect of estradiol. These results thus suggest that the high circulating levels of 17-beta-estradiol and progesterone in the umbilical vessels may be important in the regulation of PGI2 synthesis in the umbilical vessels in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043492     DOI: 10.1016/s0262-1746(82)80003-6

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  6 in total

Review 1.  Hormones and heart disease: what we thought, what we have learned, what we still need to know.

Authors:  Marian C Limacher
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  Fetal and neonatal prostacyclin and thromboxane in relation to mode of delivery.

Authors:  O Ylikorkala; M Pohjavuori; L Rovamo
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

3.  Postmenopausal oestrogen treatment and stroke: a prospective study.

Authors:  A Paganini-Hill; R K Ross; B E Henderson
Journal:  BMJ       Date:  1988 Aug 20-27

4.  Contribution to the pathogenesis of dysmenorrhea.

Authors:  H P Zahradnik; M Breckwoldt
Journal:  Arch Gynecol       Date:  1984

5.  LHRH agonists and the prevention of breast and ovarian cancer.

Authors:  M C Pike; R K Ross; R A Lobo; T J Key; M Potts; B E Henderson
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

6.  Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.

Authors:  A Aitokallio-Tallberg; J Kärkkäinen; P Pantzar; T Wahlström; O Ylikorkala
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.